Zoetis Inc. (ZTS) stock analysis

ZTS · Zoetis Inc.

Latest recorded price: USD 84.39

Model-estimated fair value: USD 88.17. This assumption-based estimate is for general research and is not investment advice.

Sector and industry: Healthcare · Drug Manufacturers - Specialty & Generic

At $84.39, ZTS trades 4.3% below the model's base-case value of $88.17. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $66.95 in the conservative case and $111.93 in the optimistic case, with a valuation confidence score of 80/100. About 76% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth 5.4%, free cash flow margin 24.1%, ROIC 24.3%. The model flags 1 risk signal for this company.

Similar companies in Healthcare